Purpose: The chemistry, pharmacology, pharmacokinetics ... Conclusion: Ximelagatran has shown promise as a possible alternative to warfarin and other anticoagulants but will require further ...

Adapted with permission from [9,21]. Events Rivaroxaban (number per 100 patient years) Warfarin (number per 100 patient years) Rivaroxaban versus warfarin hazard ratio (95% CI) Primary safety ...